Jump to top menu Jump to main menu Jump to content

Research

From fundamental science to societal solutions - our research advances knowledge, improves health, and supports people in managing their well-being.

Read more articles
  • Repeated blood tests predict heart failure risk, especially in women News

    Repeated blood tests predict heart failure risk, especially in women

    Repeated measurements of the blood marker NT-proBNP, a hormone fragment indicating heart strain, can accurately predict the risk of heart failure, particularly in women. Researchers from Erasmus MC published their findings in the scientific journal Mayo Clinic Proceedings.

    Read more
  • DNA test: who benefits from chemotherapy for ovarian cancer? News

    DNA test: who benefits from chemotherapy for ovarian cancer?

    Why does chemotherapy work for some patients and not for others? Researchers at Erasmus MC have found a promising clue in the dividing DNA of cancer cells. They hope this will enable them to predict which women with ovarian cancer will truly benefit from chemotherapy.

    Read more
  • Illness in older age is not a given: insights from 35 years of Rotterdam population research News

    Illness in older age is not a given: insights from 35 years of Rotterdam population research

    The longest-running population study in the Netherlands – The Rotterdam Study – in the Ommoord district is 35 years old. Professor of Epidemiology and research leader Arfan Ikram is still enthusiastic. The insights from ERGO have led to policy changes in the Netherlands and beyond. ‘It has triggered a change in thinking.’

    Read more
  • World’s first database for advanced cutaneous squamous cell carcinoma News

    World’s first database for advanced cutaneous squamous cell carcinoma

    Researchers at the Erasmus MC Cancer Institute have developed a nationwide database containing a wealth of information on cutaneous squamous cell carcinoma (CSCC). This resource will soon enable doctors to provide more personalized treatments for patients with this type of skin cancer.

    Read more
  • New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails News

    New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails

    Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.

    Read more
  • Nearly €20 million to drive innovation in imaging technology News

    Nearly €20 million to drive innovation in imaging technology

    A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale Research Infrastructures program. The consortium, known as AMICE (Advanced Multimodal Imaging Centers), will invest over the next decade in advancing and refining imaging technologies that are essential for cutting-edge biomedical research.

    Read more

Focus on Societal Challenges as driver of Research

As a university medical center, Erasmus MC has a great responsibility to help solve social issues related to health. The research strategy 2023-2029 ‘Focus on Societal Challenges as driver op Research’, clarifies the direction we want to take as a scientific organization at the center of society.

The strategy, which is in line with Erasmus MC’s mission and core values, describes how we can increase the impact of our research and strategically deploy the limited resources available for scientific research. And how we, together with our stakeholders, can effectively contribute to solutions, now and in the future.

Read more about our strategy

Read more about our research